T0	Participants 546 622	665 patients with a history of colorectal adenomas to three treatment groups
T1	Participants 904 1039	23 patients died, 15 were lost to follow-up, 45 refused repeat colonoscopy, and five developed severe contraindications to colonoscopy.
T2	Participants 1050 1135	552 participants who completed the follow-up examination, 94 stopped treatment early.
T3	Participants 1170 1196	28 (15.9%) of 176 patients
T4	Participants 1219 1236	58 (29.3%) of 198
T5	Participants 1261 1300	36 (20.2%) of 178 in the placebo group.
T6	Participants 1803 1845	patients with high dietary calcium intake.